These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


247 related items for PubMed ID: 9639762

  • 1. [Prenatal screening for major fetal defects by using of maternal serum markers].
    Bao P, Wu Y, Gu Q.
    Zhonghua Fu Chan Ke Za Zhi; 1997 Nov; 32(11):649-51. PubMed ID: 9639762
    [Abstract] [Full Text] [Related]

  • 2. [Prenatal maternal blood screening for the detection of fetal chromosomal abnormalities: clinical importance of the rate of false positives].
    Alvarez-Nava F, Soto M, Padrón T, Morales A, Villalobos D, Rojas de Atencio A, Prieto M, Martínez MC.
    Invest Clin; 2003 Sep; 44(3):195-207. PubMed ID: 14552058
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Maternal serum screening for birth defects: results of a Connecticut regional program.
    Benn PA, Horne D, Craffey A, Collins R, Ramsdell L, Greenstein R.
    Conn Med; 1996 Jun; 60(6):323-7. PubMed ID: 8706425
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Is screening for fetal anomalies reliable in HIV-infected pregnant women? A multicentre study.
    Brossard P, Boulvain M, Coll O, Barlow P, Aebi-Popp K, Bischof P, Martinez de Tejada B, Swiss HIV Cohort Study, Swiss HIV Mother and Child Cohort Study.
    AIDS; 2008 Oct 01; 22(15):2013-7. PubMed ID: 18784463
    [Abstract] [Full Text] [Related]

  • 12. Influence of maternal smoking on the birth prevalence of Down syndrome and on second trimester screening performance.
    Rudnicka AR, Wald NJ, Huttly W, Hackshaw AK.
    Prenat Diagn; 2002 Oct 01; 22(10):893-7. PubMed ID: 12378572
    [Abstract] [Full Text] [Related]

  • 13. Screening in early pregnancy for pre-eclampsia using Down syndrome quadruple test markers.
    Wald NJ, Morris JK, Ibison J, Wu T, George LM.
    Prenat Diagn; 2006 Jun 01; 26(6):559-64. PubMed ID: 16700087
    [Abstract] [Full Text] [Related]

  • 14. [Serum screening of fetal chromosome abnormality during second pregnancy trimester: results of 26,803 pregnant women in Jiangsu Province].
    Hu YL, Birth Defect Intervention Group of Jiangsu Province.
    Zhonghua Yi Xue Za Zhi; 2007 Sep 18; 87(35):2476-80. PubMed ID: 18067809
    [Abstract] [Full Text] [Related]

  • 15. Second-trimester maternal serum screening for Down syndrome in in vitro fertilization pregnancies.
    Rice JD, McIntosh SF, Halstead AC.
    Prenat Diagn; 2005 Mar 18; 25(3):234-8. PubMed ID: 15791658
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. The variation of risk estimates through pregnancy in second trimester maternal serum screening for Down syndrome.
    Christiansen M, Høgdall EV, Larsen SO, Høgdall C.
    Prenat Diagn; 2002 May 18; 22(5):385-7. PubMed ID: 12001192
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. The impact of correcting for smoking status when screening for chromosomal anomalies using maternal serum biochemistry and fetal nuchal translucency thickness in the first trimester of pregnancy.
    Spencer K, Bindra R, Cacho AM, Nicolaides KH.
    Prenat Diagn; 2004 Mar 18; 24(3):169-73. PubMed ID: 15057947
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 13.